Behçet and LDH/Albumin

Completed

• Conditions: Behcet's Disease; Disease Severity; Albumin; Lactate Dehydrogenase

• Registration Number: NCT06276829
• Lead Sponsor: Ataturk University

Brief Summary

ABSTRACT Objective: To investigate whether the lactate dehydrogenase to albumin ratio can be used as a parameter to determine disease severity in Behçet's disease, an inflammatory disease, by comparing it to healthy controls.

Patients and Methods: In this retrospective cohort study, patients with Behçet's disease aged 18-69 years who presented to the outpatient clinic between February 2020 and April 2023 and healthy individuals of similar age and gender were enrolled. LDH, albumin levels, and LDH/albumin ratio of both groups were compared. Clinical findings and characteristics of Behçet's patients and disease severity were recorded and analyzed in relation to LDH/albumin ratio.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-02-01
• Primary Completion: 2023-04-01
• Study Completion: 2023-04-01
• Status Verified: 2024-02
• Study First Submitted: 2024-02-18
• Study First Submitted QC: 2024-02-18
• Last Update Submitted: 2024-02-18
• Study First Posted: 2024-02-26
• Last Update Posted: 2024-02-26

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1

Inclusion Criteria

Patients with Behçet's disease aged 18-69

Exclusion Criteria

• younger than 18 years or older than 69 years, pregnant and lactating patients, patients with acute infection on admission or nutritional problems, symptomatic gastrointestinal symptoms, malignancy, hepatitis or liver disease were excluded.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
LDH/albumin ratio	February 2020 and April 2023

Trial Locations

Locations (1)

Erdal Pala; 🇹🇷 Erzurum, Turkey